Clinical Trials Directory

Trials / Completed

CompletedNCT02084901

Comparison of Biodegradable Stents: Orsiro and BioMatrix

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The use of a biodegradable polymer has the potential to reduce the sustained inflammatory response of the arterial wall, facilitating re-endothelialization and minimizing the risk of thrombus formation and late restenosis. In the study, we are going to two biodegradable polymer stents, Orsiro and BioMatrix, especially regarding the stent strut coverage by optical coherence tomography at 3 months after stent implantation. The primary objective of this study is to test the hypothesis that Orsiro is non-inferior to Biomatrix in terms of stent strut coverage by optical coherence tomography at 3 months. The secondary endpoint is clinical outcomes up to 1 year.

Detailed description

The use of a biodegradable polymer has the potential to reduce the sustained inflammatory response of the arterial wall, facilitating re-endothelialization and minimizing the risk of thrombus formation and late restenosis. In the study, we are going to two biodegradable polymer stents, Orsiro and BioMatrix, especially regarding the stent strut coverage by optical coherence tomography at 3 months after stent implantation. The primary objective of this study is to test the hypothesis that Orsiro is non-inferior to Biomatrix in terms of stent strut coverage by optical coherence tomography at 3 months. The secondary endpoint is clinical outcomes up to 1 year.

Conditions

Interventions

TypeNameDescription
DEVICEDrug-eluting biodegradable stent Orsiro implantationDrug-eluting biodegradable stent Orsiro implantation
DEVICEDrug-eluting biodegradable stent BioMatrix or BioMatrix Flex implantationDrug-eluting biodegradable stent BioMatrix or BioMatrix Flex implantation

Timeline

Start date
2014-03-01
Primary completion
2015-03-01
Completion
2016-03-01
First posted
2014-03-12
Last updated
2016-07-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02084901. Inclusion in this directory is not an endorsement.